A biopharmaceutical company committed to applying its scientific leadership in cellular metabolism to transform the lives of patients with cancer and rare genetic disorders.  We are growing rapidly with a diverse robust pipeline. We have multiple first-in-class product candidates in late-stage clinical development including AG-221 and AG-120 for AML.  CEO, David Schenkein, formerly of Genentech and Millennium, was voted one of FierceBiotech's Top 25 Most Influential Biopharmaceutical Leaders in 2015.

Agios Cambridge, MA, USA
Mar 02, 2018
Agios Pharmaceuticals is searching for a statistician Intern to join our statistic group.  The summer intern will have the opportunity to work with a senior statistician on a project involving statistic considerations and method in Patient Reported Outcome (PRO) development, including considerations in PRO in-trial validation and its impact on the analyses in the registration trials. Key Responsibilities Perform statistical, clinical, and regulatory literature reviews on various methodologies PRO development Develop SAS/R programs to implement these methodologies Perform other duties as assigned Give regular progress updates to manager and mentor Prepare a final report of work and make a presentation to the Biostatistics staff meeting and on intern poster day Minimum Requirements Currently enrolled in a graduate-level curriculum leading to a PhD in statistics, biostatistics or highly related field Completed at least two, preferable three, full years of graduate study before the start of the internship in summer Preferred Qualifications Solid statistical background with proven research abilities Strong written and verbal communication skills Prior internship or co/op experience Excellent programming skills in SAS, R; Highly motivated and detail oriented